TITLE

Insulin and glucose play a role in foam cell formation and function

AUTHOR(S)
Shashkin, Pavel N.; Jain, Nitin; Miller, Yury I.; Rissing, Benjamin A.; Yuqing Huo; Keller, Susanna R.; Vandenhoff, George E.; Nadler, Jerry L.; McIntyre, Thomas M.
PUB. DATE
January 2006
SOURCE
Cardiovascular Diabetology;2006, Vol. 5, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Foam cell formation in diabetic patients often occurs in the presence of high insulin and glucose levels. To test whether hyperinsulinemic hyperglycemic conditions affect foam cell differentiation, we examined gene expression, cytokine production, and Akt phosphorylation in human monocyte-derived macrophages incubated with two types of oxidized low density lipoprotein (LDL), minimally modified LDL (mmLDL) and extensively oxidized LDL (OxLDL). Methods and results: Using Affymetrix GeneChip® arrays, we found that several genes directly related to insulin signaling were changed. The insulin receptor and glucose-6-phosphate dehydrogenase were upregulated by mmLDL and OxLDL, whereas insulin-induced gene 1 was significantly downregulated. In hyperinsulinemic hyperglycemic conditions, modified LDL upregulated Akt phosphorylation and expression of the insulin-regulated aminopeptidase. The level of proinflammatory cytokines, IL-lβ, IL-12, and IL-6, and of a 5-lipoxygenase eicosanoid, 5- hydroxyeicosatetraenoic acid (5-HETE), was also increased. Conclusion: These results suggest that the exposure of macrophages to modified low density lipoproteins in hyperglycemic hyperinsulinemic conditions affects insulin signaling and promotes the release of proinflammatory stimuli, such as cytokines and eicosanoids. These in turn may contribute to the development of insulin resistance.
ACCESSION #
28682798

 

Related Articles

  • Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo. Konstantopoulos, Nicky; Molero, Juan C.; McGee, Sean L.; Spolding, Briana; Connor, Tim; de Vries, Melissa; Wanyonyi, Stephen; Fahey, Richard; Morrison, Shona; Swinton, Courtney; Jones, Sharon; Cooper, Adrian; Garcia.-Guerra, Lucia; Foletta, Victoria C.; Krippner, Guy; Andrikopoulos, Sofianos; Walder, Ken R. // Diabetes;Aug2012, Vol. 61 Issue 8, p2146 

    We previously used Gene Expression Signature technology to identify methazolamide (MTZ) and related compounds with insulin sensitizing activity in vitro. The effects of these compounds were investigated in diabetic db/db mice, insulin-resistant diet-induced obese (DIO) mice, and rats with...

  • Insulin Signaling and Glucose Transport in Skeletal Muscle From First-Degree Relatives of Type 2 Diabetic Patients. Karlsson, Håkan K. R.; Ahlsén, Maria; Zierath, Juleen R.; Wallberg-Henriksson, Harriet; Koistinen, Heikki A. // Diabetes;May2006, Vol. 55 Issue 5, p1283 

    Aberrant insulin signaling and glucose metabolism in skeletal muscle from type 2 diabetic patients may arise from genetic defects and an altered metabolic milieu. We determined insulin action on signal transduction and glucose transport in isolated vastus lateralis skeletal muscle from normal...

  • Diabetic Nephropathy Is Associated With Gene Expression Levels of Oxidative Phosphorylation and Related Pathways. Huang, Chunmei; Kim, Youngki; Caramori, M. Luiza; Moore, Jason H.; Rich, Stephen S.; Mychaleckyj, Josyf C.; Walker, Paul C.; Mauer, Michael // Diabetes;Jun2006, Vol. 55 Issue 6, p1826 

    The in vitro behavior of skin fibroblasts from patients with or without diabetic nephropathy is associated with diabetic nephropathy risk. Here we compared skin fibroblast gene expression profiles from two groups of type 1 diabetic patients: 20 with very fast ("fast-track") versus 20 with very...

  • Nutrigenomics, β-Cell Function and Type 2 Diabetes. Nino-Fong, R.; Collins, T. M.; Chan, C. B. // Current Genomics;Mar2007, Vol. 8 Issue 1, p29 

    “Nutrigenomics” refers to the ability of nutrients to alter gene expression. Insulin secreting β-cells exhibit genomic and molecular changes that enhance their function when acutely exposed to physiological concentrations of glucose and fatty acids. However, chronic exposure, such...

  • ChREBP-β isoform: A novel target for diabetes treatment.  // Diabetes Digest;2012, Vol. 11 Issue 3, p149 

    The article discusses a study to evaluate a novel carbohydrate-responsive element-binding protein (ChREBP) isoform in adipose tissue regulates systemic glucose metabolism, which found that in obese people, ChREBPß expression correlates with insulin sensitivity.

  • Preservation of Metabolic Flexibility in Skeletal Muscle by a Combined Use of n-3 PUFA and Rosiglitazone in Dietary Obese Mice. Horakova, Olga; Medrikova, Dasa; Van Schothorst, Evert M.; Bunschoten, Annelies; Flachs, Pavel; Kus, Vladimir; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Hensler, Michal; Rossmeisl, Martin; Wang-Sattler, Rui; Prehn, Cornelia; Adamski, Jerzy; Illig, Thomas; Keijer, Jaap; Kopecky, Jan; Blanc, Stephane // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Insulin resistance, the key defect in type 2 diabetes (T2D), is associated with a low capacity to adapt fuel oxidation to fuel availability, i.e., metabolic inflexibility. This, in turn, contributes to a further damage of insulin signaling. Effectiveness of T2D treatment depends in large part...

  • Crosstalk Between Inflammation and Insulin Resistance in Insulin Target Tissues: Nfkb Represses Glut4 Gene Promoter. Karni, Shiri; Armoni, Michal; Harel, Chava; Milo, Simcha; Karnieli, Eddy // Diabetes;Jun2007 Supplement 1, Vol. 56, pA345 

    The link between inflammation, insulin resistance and type 2 diabetes mellitus (DM2) is now well-established. Since NFkB activity is enhanced in DM2, we studied its role in regulating glucose transporter 4 (GLUT4) gene in bona fide insulin target tissues. Endogenous gene expression was studied...

  • Central insulin action regulates peripheral glucose and fat metabolism in mice. Koch, Linda; Wunderlich, F. Thomas; Seibler, Jost; Könner, A. Christine; Hampel, Brigitte; Irlenbusch, Sigrid; Brabant, Georg; Kahn, C. Ronald; Schwenk, Frieder; Brüning, Jens C. // Journal of Clinical Investigation;Jun2008, Vol. 118 Issue 6, p2132 

    Insulin resistance is a hallmark of type 2 diabetes, and many insights into the functions of insulin have been gained through the study of mice lacking the IR. To gain a better understanding of the role of insulin action in the brain versus peripheral tissues, we created 2 mouse models with...

  • Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects With Type 2 Diabetes. Sriwijitkamol, Apiradee; Coletta, Dawn K.; Wajcberg, Estela; Balbontin, Gabriela B.; Reyna, Sara M.; Barrientes, John; Eagan, Phyllis A.; Jenkinson, Christopher P.; Cersosimo, Eugenio; DeFronzo, Ralph A.; Sakamoto, Kei; Musi, Nicolas // Diabetes;Mar2007, Vol. 56 Issue 3, p836 

    Activation of AMP-activated protein kinase (AMPK) by exercise induces several cellular processes in muscle. Exercise activation of AMPK is unaffected in lean (BMI ∼25 kg/m²) subjects with type 2 diabetes. However, most type 2 diabetic subjects are obese (BMI >30 kg/m²), and exercise...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics